Executive Summary
Nyxoah has filed an IPR petition challenging Inspire Medical's U.S. Pat. 10,898,709, asserting that all 15 claims are obvious over earlier neurostimulation disclosures such as Durand, Hoegh, Headley and Tran. The petition seeks institution of review and cancellation of the claims.
Related Cases
Tableau Software, LLC et al.vsiCharts LLC
iCharts LLC seeks Director Review to overturn the PTAB’s decision to institute an IPR against its 2012 data‑visualization patent, arguing the case would duplicate district‑court litigation and waste Board resources.
Meta Platforms, Inc.vsSitnet, LLC
Meta Platforms successfully secured institution in its IPR challenge against Sitnet, LLC's '454 patent. The Board found sufficient support for obviousness over Amidon and Wong/Gogic, advancing the dispute to trial.
Imperative Care, Inc.vsINARI MEDICAL, INC.
Imperative Care, Inc. filed an IPR challenging INARI MEDICAL, INC.'s patent on Intravascular Catheter Valves. The petitioner asserts that the claims are anticipated by Schaffer or rendered obvious through combinations of Hartley and Eller.
Phison Electronics CorporationvsVervain, LLC
The PTAB denied Phison Electronics’ petition for post‑grant review of Vervain’s NAND‑flash patent, finding no sufficient evidence that claims 1‑6 are unpatentable.
Fifth Third Bank, National AssociationvsUnited Services Automobile Association
USAA and Regions Bank have reached a settlement in principle and jointly filed a motion to stay all deadlines while finalizing the agreement. The motion seeks a 14‑day stay to file dismissal papers.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.